Luteinizing Hormone Secretion Is Not Influenced by Insulin Infusion in Women with Polycystic Ovary Syndrome Despite Improved Insulin Sensitivity during Pioglitazone Treatment
The DOI matches its Crossref record; 42 of the 48 references it cites were found in a registry or an index.
Abstract
It has been reported in women with polycystic ovary syndrome (PCOS) that LH secretion is not altered by insulin infusion. To determine whether insulin resistance may have precluded an effect of insulin, pulsatile LH secretion and gonadotropin responses to GnRH were examined in PCOS women (n = 9) before and after pioglitazone treatment (45 mg/d) for 20 wk in the presence and absence of a hyperinsulinemic euglycemic clamp (80 mU/m2.min). Frequent blood samples were obtained for 12 h (every 10 min) as well as during sequential administration of GnRH at doses of 2, 10, and 20 microg over 12 h. A significant (P < 0.05) improvement in insulin sensitivity was seen in the subjects after treatment. Mean LH levels, LH pulse frequency and amplitude, as well as gonadotropin responses to GnRH were not influenced by pioglitazone, either with or without insulin infusion. We conclude that in PCOS women, inappropriate gonadotropin release does not appear to be a consequence of hyperinsulinemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
DUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
Azziz, R., Ehrmann, D., Legro, R. S., Whitcomb, R. W., Hanley, R., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7375 · Cited by 517
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Obesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Obesity and polycystic ovary syndrome
Barber, T. M., & Franks, S. (2021) · Clinical Endocrinology · doi:10.1111/cen.14421 · Cited by 385
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
Basic Infertility Including Polycystic Ovary Syndrome
Brassard, M., AinMelk, Y., & Baillargeon, J.-P. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.04.008 · Cited by 180
The relationship between gut and adipose hormones, and reproduction
Comninos, A. N., Jayasena, C. N., & Dhillo, W. S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt033 · Cited by 167
Brothers, K. J., Wu, S., DiVall, S. A., Messmer, M. R., Kahn, C. R., Miller, R. S., Radovick, S., Wondisford, F. E., & Wolfe, A. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.010 · Cited by 157
The reproductive phenotype in polycystic ovary syndrome
Chang, R. J. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0637 · Cited by 145
Self-citationMalini, N. A., & George, K. R. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.12.007 · Cited by 145
“In women with PCOS, infusions of exogenous insulin do not change LH secretion (Mehta et al., 2005), and decrease of insulin in PCOS has unpredictable effects on LH levels (Poretsky et al., 1999).”
BackgroundRosenfield, R. L., & Bordini, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.088 · Cited by 103
Tosi, F., Negri, C., Perrone, F., Dorizzi, R., Castello, R., Bonora, E., & Moghetti, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2939 · Cited by 90
Kent, S. C., Gnatuk, C. L., Kunselman, A. R., Demers, L. M., Lee, P. A., & Legro, R. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1958 · Cited by 89
The Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E., Adashi, E. Y., & Bulun, S. E. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50018-2 · Cited by 92
Moret, M., Stettler, R., Rodieux, F., Gaillard, R. C., Waeber, G., Wirthner, D., Giusti, V., Tappy, L., & Pralong, F. P. (2009) · Neuroendocrinology · doi:10.1159/000160911 · Cited by 72
of the Drug and Therapeutics Committee of the Pediatric Endocrine Society, Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
Aroda, V. R., Ciaraldi, T. P., Burke, P., Mudaliar, S., Clopton, P., Phillips, S., Chang, R. J., & Henry, R. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1133 · Cited by 71
Self-citationGlintborg, D., Hermann, A. P., Andersen, M., Hagen, C., Beck‐Nielsen, H., Veldhuis, J. D., & Henriksen, J. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.067 · Cited by 73
Lawson, M. A., Jain, S., Sun, S., Patel, K., Malcolm, P. J., & Chang, R. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2656 · Cited by 67
“Of these individuals, 11 PCOS and nine normal women were further examined for LH responses to increasing GnRH dose before and during a fixed dose of insulin infusion as previously described (12, 25).”
MethodSelf-citationYoo, R. Y., Dewan, A. K., Basu, R., Newfield, R. S., Gottschalk, M. E., & Chang, R. J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.037 · Cited by 65
Self-citationThiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
Froment, P., & Touraine, P. (2006) · PPAR Research · doi:10.1155/ppar/2006/73986 · Cited by 58
PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility
Minge, C. E., Robker, R. L., & Norman, R. J. (2008) · PPAR Research · doi:10.1155/2008/243791 · Cited by 60
The role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 56
Peroxisome Proliferator‐Activated Receptors: New Players in the Field of Reproduction
Tóth, B., Hornung, D., Scholz, C., Djalali, S., Friese, K., & Jeschke, U. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00514.x · Cited by 53
Kyei, G., Sobhani, A., Nekoonam, S., Shabani, M., Ebrahimi, F., Qasemi, M., Salahi, E., & Amidi, F. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04279 · Cited by 43
“High level of insulin further disturb hypothalamic-pituitary axis leading to high amount of LH [24, 25].”
BackgroundMenstrual Health and the Metabolic Syndrome in Adolescents
Tfayli, H. M., & Arslanian, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.024 · Cited by 45
Bungum, L. J., Franssohn, F., Bungum, M., Humaidan, P., & Giwercman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068223 · Cited by 41
Salloum, B. A., Herkimer, C., Lee, J. S., Veiga‐Lopez, A., & Padmanabhan, V. (2012) · Endocrinology · doi:10.1210/en.2011-2074 · Cited by 32
Sharma, S., Sharma, P. M., Mistry, D. S., Chang, R. J., Olefsky, J. M., Mellon, P. L., & Webster, N. J. G. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.088005 · Cited by 34
“[15] showed that pioglitazone therapy reduces peak serum LH responses to multidose GnRH, which indicates that absolute pituitary responsiveness, but not sensitivity, is altered in vivo.”
BackgroundSelf-citationKatcher, H. I., Kunselman, A. R., Dmitrović, R., Demers, L. M., Gnatuk, C. L., Kris‐Etherton, P. M., & Legro, R. S. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.035 · Cited by 29
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 29
Fernandez, M. O., Sharma, S., Kim, S., Rickert, E., Hsueh, K., Hwang, V., Olefsky, J. M., & Webster, N. J. G. (2016) · Endocrinology · doi:10.1210/en.2016-1818 · Cited by 31
Obesity in Adolescent Girls: Is Excess Androgen the Real Bad Actor?
Marshall, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2665 · Cited by 23
Dasgupta, A., Khan, A., Banerjee, U., Ghosh, M., Pal, M., Chowdhury, K. M., & Dasgupta, S. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0253-4 · Cited by 20
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Insulin Resistance in Polycystic Ovarian Disease
Bhatia, V. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000177251.15366.85 · Cited by 15
Insulin Action in Polycystic Ovary Syndrome: In Vivo and In Vitro
Baillargeon, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_4 · Cited by 12
“Similarly, 16- and 20-week treatment with the thiazolidinedione pioglitazone in obese PCOS women did not alter LH pulse patterns, despite improvement in insulin sensitivity [ 51 ,53].”
BackgroundUlloa‐Aguirre, A., Portocarrero-Ortiz, L. A., Zariñán, T., Olivares, A., Carranza‐Lira, S., Veldhuis, J. D., & López-Alvarenga, J. C. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61079-6 · Cited by 10
Polycystic Ovary Syndrome: Reproductive Aspects
Chang, R. J. (2022) · doi:10.1093/med/9780198870197.003.0159 · Cited by 7
Self-citationAltered multihormone synchrony in obese patients with polycystic ovary syndrome
Roelfsema, F., Kok, P., Veldhuis, J. D., & Pijl, H. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.011 · Cited by 7
Shim, A. R., Hwang, Y. I., Lim, K. J., Choi, Y., Jeon, Y. E., Seo, S. K., Cho, S., Choi, Y. S., & Lee, B. S. (2011) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2011.54.11.659 · Cited by 7
Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Clínicas médicas de Norteamérica · doi:10.1016/s0186-0194(08)92058-x · Cited by 2
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Hypothalamic-Pituitary-Gonadotropic Dysfunction in the Polycystic Ovary Syndrome
Chang, R. J., & Mehta, R. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_17
“In particular, endogenous serum LH levels were unchanged prior to and immediately following initiation of the insulin clamp (Table 1). In an extension of these studies, episodic LH secretion and LH responses to GnRH stimulation were not influenced by an insulin-lowering drug, pioglitazone, administered for 3 months (F…”
BackgroundSelf-citationPubertal Precursors of the Polycystic Ovarian Syndrome
Marshall, J. C., McCartney, C. R., Blank, S. K., & Okonkwo, Q. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_7
“However, its potential role in the neuroendocrine abnormalities is unclear, and insulin does not augment gonadotrope responses to GnRH nor do insulin infusions alter LH secretion (35, 36 ).”
Background(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235329.84906.3b
Polycystic Ovary Syndrome in the Peripubertal Period
Witchel, S. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_13
Metadata
- Authors
- Mehta, R. V., Patel, K. S., Coffler, M. S., Dahan, M. H., Yoo, R. Y., Archer, J. S., Malcom, P. J., & Chang, R. J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Chang, R. Jeffrey
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-04
- Volume
- 90
- Issue
- 4
- Pages
- 2136-2141
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126627556
- Cited by
- 47
- References
- 48
- Citations by year
- 2022: 1 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 3 · 2012: 3
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HD-12303)
- National Institute of Child Health and Human Development
- National Center for Research Resources (M01RR000827)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32-HDO-7203, U54HD012303, U54-HD-12303-20)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, luteinizing hormone secretion, insulin resistance, insulin sensitivity, pioglitazone, insulin infusion, hyperinsulinemia, pulsatile LH secretion, GnRH stimulation, gonadotropin response, insulin sensitizers
- MeSH terms
- Pioglitazone, Adult, Androstenedione, Female, Humans, Hypoglycemic Agents, Insulin, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Polycystic Ovary Syndrome, Testosterone, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.